https://blog.twitter.com/en_us/topics/product/2021/introducing-super-follows
Related Posts
Goldman Sachs Upgrades Delek US Hldgs to Neutral, Announces $24 Price Target
Goldman Sachs analyst Neil Mehta upgrades Delek US Hldgs (NYSE:DK) from Sell to Neutral and announces $24 price target.
Dicerna Announces Interim Results From Phase 1 Trial Of Belcesiran For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Interim Results From Phase 1 Study Enabled Initiation and First Patient Dosing in Phase 2 ESTRELLA Study, Which Is Currently Underway –
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) (the
Morgan Stanley Maintains Overweight on APA, Raises Price Target to $41
Morgan Stanley analyst Devin McDermott maintains APA (NASDAQ:APA) with a Overweight and raises the price target from $39 to $41.